-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Vanda Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Vanda Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$11M, a 83.5% decline year-over-year.
- Vanda Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$37.5M, a 16265% decline year-over-year.
- Vanda Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$14M, a 320% decline from 2022.
- Vanda Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was $6.33M, a 85% decline from 2021.
- Vanda Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was $42.2M, a 54.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)